A novel heterologous expression system was used to examine the coupling of metabotropic glutamate receptors (mGluRs) to neuronal voltage-gated ion channels. Cytoplasm ic injection of mGluR2 cRNA into adult rat sympathetic neurons resulted in the expression of receptors that negatively coupled to N-type Ca 2+ channels through a pertussis toxin-sensitive pathway. Injection of mGluRla cRNA resulted in the expression of receptors that inhibited M-type K ÷ channels via a pertussis toxin-insensitive pathway. Coupling was restricted to specific transduction elements and effectors, since mGluR2 did not inhibit M channels and mGluRla had minimal effects on Ca 2÷ channels. These findings demonstrate that heterologously expressed, and thus unambiguously identified, mGluR subtypes modulate specific neuronal ion channels through discrete signal transduction pathways.
Introduction
Two families of receptors, ionotropic and metabotropic, are known to mediate the actions of glutamate in the mammalian CNS. Ionotropic glutamate receptors (iGluRs) are heteromultimeric proteins that contain an integral ion channel and account for the majority of fast excitatory synaptic transmission in the mammalian CNS. In contrast, the metabotropic glutamate receptor (mGluR) family is comprised of monomeric proteins that couple to effectors (e.g., ion channels and enzymes) by interacting with heterotrimeric guanine nucleotide-binding proteins (G proteins) . At present, seven distinct mGluR subtypes (mGluR1-7) have been cloned, along with splice variants of mGluR1, mGluR4, and mGluR5. The mGluR subtypes can be arranged into three groups based on agonist pharmacology, coupling to specific signal transduction pathways, and sequence homology (recently reviewed by Hollman and Heinemann, 1994; Nakanishi, 1994; Nakanishi and Masu, 1994; Pin and Duvoisin, 1995) . Group I receptors, comprised of splice variants of mGluR1 and mGluR5, are potently activated by L-quisqualate and produce large increases in inositol phosphate (IP) turnover in stably transfected clonal cells (Houamed et al., 1991; Masu et al., 1991; Aramori and Nakanishi, 1992; Abe et al., 1992; Pin et al., 1992; Thomsen et al., 1993) . Conversely, group II (mGluR2 and mGluR3) and III (mGluR4, mGluR6, and mGluR7) receptors, when expressed in nonneuronal systems, have little effect on IP turnover, negatively couple to adenylate cyclase (AC), and are relatively insensitive to L-quisqualate Nakajima et al., 1993; Tanabe et al., 1993; Okamoto et al., 1994; Saugstad et al., 1994) . Group II and III receptors can be functionally distinguished on the basis of agonist pharmacology. (2S,l'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl) glycine (DCG-IV) and (2S, l'S,2's)-2-(carboxycyclopropyl) glycine (L-CCG-I) appear to be relatively specific agonists of group II mGlu Rs (Hayashi et al., 1992; Hayashi et al., 1993) , whereas L-2-amino-4-phosphonobutyric acid (L-AP4) and L-serine-Ophosphate (L-SOP) are relatively specific agonists of group III mGluRs Nakajima et al., 1993; Okamoto et al., 1994; Saugstad et al., 1994) .
Natively expressed mGluRs are involved in a variety of important physiological functions in CNS neurons, including ion channel modulation, regulation of neurotransmitter release, and possibly modulation of long-term potentiation and depression (Pin and Duvoisin, 1995) . Moreover, mGluRs may play a role in pathological processes such as epilepsy and excitotoxicity (Schoepp and Conn, 1993) . Thus, there is a substantial interest in developing subtypespecific pharmacological agents and defining the role subserved by specific mGluR subtypes. The recent availability of cDNA clones for the mGluRs has generated much new knowledge concerning the function of specific mGluR subtypes; however, the application of this information to neuronal function has generally required extrapolation of data derived from heterologous expression in nonneuronal cells. In this study, we show that injection of cRNA coding for specific mGluRs into the cytoplasm of neurons normally devoid of these receptors, namely adult rat sympathetic neurons, results in the rapid and robust expression of mGluRs. We use this expression strategy to investigate the subtype-specific coupling of mGluRla and mGluR2 to endogenous N-type Ca 2÷ and M-type K ÷ channels--proteins known to influence neuronal excitability (Brown and Adams, 1980) and neurotransmitter release (Hirning et al., 1988) .
Results

Heterologously Expressed mGluR2 Couples to Ca 2+ Channels
As L-glutamate is primarily a CNS neurotransmitter and postganglionic sympathetic neurons do not synapse directly with CNS neurons, it was hypothesized that rat superior cervical ganglion (SCG) neurons would be devoid of GluR responses. This hypothesis was supported by the data in Figure 1A , which depicts Ca 2+ current traces recorded from dissociated rat SCG neurons using the wholecell variant of the patch-clamp technique (Hamill et al., 1981) . Ca 2÷ currents were evoked every 10 s with a 70 ms depolarizing test pulse to +10 mV from a holding potential of -80 mV in solutions designed to isolate voltagedependent Ic, from other voltage-gated currents (see Ex- perimental Procedures). In these neurons, the Ca 2+ current has been shown to arise primarily (65%-95%) from (o-conotoxin GVIA-sensitive N-type Ca 2+ channels (Plummeret al., 1989; Ikeda, 1991; Regan et al., 1991; Mintz et al., 1992; Boland et al., 1994) . Application of 100 p,M L-glutamate to control (uninjected) neurons produced no apparent alteration in Ca 2+ current amplitude or time course ( Figure 1A ). In contrast, Ca 2+ current amplitude in neurons previously (14-24 hr) injected with mGluR2 cRNA was greatly attenuated by 100 pM L-glutamate ( (D) Superimposed Ica traces recorded with a double-pulse voltage protocol (lower inset) in the absence (lower traces) or presence (upper traces) of (lS,3R)-ACPD (100 p.M), a mGluR-selective agonist, in a mGluR2-injected neuron. The current generated by the first 25 ms test pulse to +10 mV is denoted the pre current and the current evoked by the second test pulse following a 50 ms conditioning pulse to +80 mV is denoted the post current. (E) Time course of Ica facilitation during ACPD application. Facilitation is defined as the ratio of post to pre current (measured at 10 ms after the onset of the test pulse). Application of (lS,3R)-AC PD (100 pM) was applied during the times indicated (closed bars). Data derived from the neuron shown in (D) using an identical voltage protocol. 1 B, left). This effect was rapid, completely reversible, and displayed no apparent tachyphylaxis upon a subsequent application of agonist. The mean decrease in Ica amplitude, measured isochronally 10 ms from the onset of the test pulse, is summarized in Figure 1C , Ca 2+ current inhibition produced by 100 I~M L-glutamate for control (uninjected), mGluRlc~-injected, and mGluR2-injected neurons was-0.57% _ 1.4% (n = 9),6.8°/o --. 4.0% (n = 9), and 63.5% -+ 4.6% (n = 9), respectively. In this set of experiments, inhibition of Ica was detected in every neuron previously injected with mGluR2 cRNA (range, 37%- the "willing-reluctant" model (Bean, 1989; Elmslie et al., 1990; Boland and Bean, 1993) of Ca 2+ channel modulation. The effect of voltage on mGluR2-mediated Ic, inhibition is illustrated in Figure 2 . Figure 2A depicts superimposed Ica traces recorded in the absence (lower traces) or presence (upper traces) of 100 IX M L-giutamate at two different test potentials. Ica inhibition was greater at 0 mV ( Figure  2A , left) than at a test potential of +40 mV (Figure 2A , right). Mean Ic~ inhibitions for three neurons determined at test potentials of 0 and +40 mV were 51% _+ 5% and 27% _+ 4%, respectively. Current-voltage relationships obtained in the absence or presence of 100 I~M L-glutamate are shown as open and closed circles in Figure 2B . The highly voltage-dependent nature of mGluR2-mediated Ica inhibition is well illustrated by the bell-shaped relationship ( Figure 2C ) between Ica inhibition and test pulse potential (Ikeda, 1992; Zhu and Ikeda, 1993) . Maximal inhibition occurred over the voltage range of 0 to 10 mV. The ability of large depolarizing conditioning pulses to relieve mGluR2-mediated Ica inhibition is illustrated in Figure 2D . Ca 2÷ currents were evoked with a double-pulse voltage protocol (Elmslie et al., 1990) in the absence ( Figure 2D , lower trace) or presence ( Figure 2D , upper trace) of 100 ~.M (1S,3R)-l-aminocyclopentane-l,3-dicarboxylic acid (ACPD), a mGluR-selective agonist. Under control conditions, the current evoked following a large depolarization (post current) was slightly larger (-16%; see Ikeda, 1991) than the current generated by an identical test pulse preceding the conditioning pulse (pre current). Application of 100 ~M (1S,3R)-ACPD produced a 62% decrease in pre current amplitude and characteristic slowing of the current rising phase. In contrast, the post current was depressed only 18% and no longer exhibited an altered time course. For five neurons, application of 100 I~M L-glutamate or (lS,3R)-ACPD produced a 68% _ 3% decrease in the pre current and only a 27% __. 3% decrease in the post current. Thus, the 50 ms conditioning pulse to +80 mV relieved the majority, but not all, of the Ica inhibition produced by (1S,3R)-ACPD. Finally, the ratio of post to pre current, or facilitation, is increased rapidly and reversibly by mGluR2 activation ( Figure 2E ). Mean facilitation increased from 1.10 _ 0.02 to 2.55 _ 0.14 (n = 5)during application of 100 t~M L-glutamate or (1S,3R)-ACPD. 770). Conversely, Ica of neurons previously injected with mGluRle cRNA was unaffected (<10% inhibition) in six of nine neurons; three neurons demonstrated small inhibitions (range, 13o-26o).
The rising phase of Ica in the presence of L-glutamate exhibited a prom inent biphasic or "slowed" trajectory ( Figure 1 B, right) reminiscent of the effect produced by activation of several natively expressed G protein-coupled receptors, for example, somatostatin (Ikeda and Schofield, 1989) , e2-adrenergic (Schofield, 1991) , prostaglandin (Ikeda, i992) , adenosine (Zhu and Ikeda, 1993) , and VIP/ secretin (Zhu and Ikeda, 1994) . The "slowing" of the activation phase has been proposed to arise from a voltagedependent relief of block during the test pulse and can be accounted for, at least qualitatively, by variations of
Pharmacology of mGluR2-Mediated Ic. Inhibition
The agonist pharmacology of mGluR2-mediated lea inhibition was characterized as illustrated in Figure 3 . Figure  3A depicts the protocol used to derive concentrationresponse curves for a series of mGluR agonists. Ca 2÷ currents were evoked every 10 s with 70 ms test pulse to +10 mV from a holding potential of -80 mV. Note that maximal inhibition occurred near this test pulse potential (see Figure 2C) . After the current amplitude had stabilized following patch rupture, increasing concentrations of a single agonist were sequentially applied to a single neuron for periods of about 20 s ( Figure 3A , bars), a time sufficient for Ica inhibition to reach maximum values. Between drug applications, Ica rapidly (10-20 s) recovered to near baseline amplitude. The normalized concentration-response curve for an agonist ( Figure 3B ) was determined by fitting (nonlinear least squares) a single binding site isotherm ( Figure 3B , solid line) to the Ica inhibition data and then normalizing the data to the maximum inhibition parameter. The rank order of agonist potency for mGlu R2-mediated Ica inhibition obtained in this way was DCG-IV > L-glutamate > (IS,3R)-ACPD >> L-SOP, L-AP4, L-quisqualate, (1R,3$)-ACPD. For the three active agonists, the mean EC~0 for DCG-IV (n = 5), L-glutamate (n = 5), and (lS,3R)-ACPD (n = 5) inhibition of Ica was 0.11 _+ 0.02 I~M, 1.8 _+ 0.4 I~M, and 3.7 _+ 0.2 ~M, respectively, and the maximum block of lca was 45% _+ 5% , 48% _+ 12%,and56% _+ 4%, respectively.
The impotency of both L-quisqualate and L-AP4 in regard to Ic, inhibition is particularly important in that these compounds have been shown to inhibit high threshold Ca 2÷ channels in CNS neurons. In fact, L-quisqualate was the most potent agonist in depressing Ica of acutely isolated hippocampal CA3 pyramidal neurons (Swartz and Bean, 1992) . Th us, these com pounds were always "bracketed" with active agonists serving as positive controls to assure that lack of agonist response could not be attributed to variations in mGluR2 expression or desensitization. Successive application of 100 I~M L-glutamate, L-AP4, L-quisqualate, and (lS,3R)-ACPD to single neurons (n = 4) resulted in mean Ica inhibition of 52% __ 9%, 4.70/0 __ 1.7%, 3.1% __. 1.6%, and 44% _+ 6.9%, respectively (data not shown). The stereoselectivity of agonist response was determined using resolved enantiomers of trans-ACPD. Application of 100 I~M (18,3R)-ACPD, (1R,3S)-ACPD, and (lS,3R)-ACPD in succession to single neurons (n = 4) resulted in mean Ica inhibition of 58% _+ 6%, 2.6 -4-1.5%, and 57% __ 6%, respectively (data not shown). Figure 4A illustrates the effect of the mGluR antagonist ( _+ )-~-methyl-4-carboxyphenylglycine (MCPG; . A "bracketed" protocol was used to evaluate the ability of 500 I~M MCPG to antagonize Ic~ inhibition produced by 3 I~M (lS,3R)-ACPD (a concentration approximately equal to the ECso). Successive applications of 3 I~M (tS,3R)-ACPD (first application), 500 I~M (--4-)-MCPG, ( _ )-MCPG/(1S,3R)-ACPD combined, and (lS,3R)-ACPD (second application) to single neurons (n = 4) resulted in mean Ica inhibition of 39% -+ 5%, 3.6% -1.0% , 10% _ 20, and 36% + 2%, respectively ( Figure 4B ). Thus, (_+)-MCPG alone produced no detectable Ica inhibition but effectively and reversibly antagonized (lS,3R)-ACPDinduced Ica inhibition.
Heterologously Expressed mGluRl~ Couples to M-type K* Channels
The M current (IM) is a noninactivating K ÷ conductance found in both PNS and CNS neurons that is highly modulated and known to influence electrical excitability (Brown and Adams, 1980) . IM recordings from SCG neurons were made with the whole-cell patch-clamp technique using pipette and external solutions that approximate physiological conditions (see Experimental Procedures). SCG neurons were voltage-clamped at a holding potential of -30 mV (which serves to inactivate other K ÷ currents)'and periodically (0.1 Hz) stepped to -60 mV for 0.5 s ( Figure 5A , left trace). IM amplitude was determined from the magnitude of the slow"tail current" ( Figure 5A , left trace, arrows), which results from M channel deactivation during the sojourn to -60 mV. Under these conditions, application of L-glutamate (100 p.M) to control neurons (i.e., uninjected) produced no apparent change in the IM amplitude or time course ( Figure  5A , left and right trace). In addition, there was no detectable change in steady-state current at either -30 mV or -60 mV; hence iGluR-mediated responses are not present in SCG neurons, at least under these conditions. In neurons that had been injected 14-24 hr prior to recording with mGluRla cRNA, application of L-glutamate (100 I~M) resulted in a rapid and reversible inhibition of IM amplitude ( Figure 5B , left). The inhibition was characterized by a decrease in both the steady-state outward current at -30 mV and the time-dependent current relaxation at -60 mV ( Figure 5B , right trace). Similar effects are produced by activation of natively expressed muscarinic acetylcholine receptors in these neurons (Brown et al., 1989; Bernheim et al., 1992) . Figure 5C summarizes the decrease in IM amplitude produced by L-glutamate (100 I~M). Mean inhibition of IM amplitude for control (uninjected), mGluRla-injected, and mGluR2-injected neurons was 1.4% _+ 1% (n = 12), 81% _+ 5% (n = 10), and -0.4% _+ 2.4% (n = 8), respectively.
Pharmacology of mGluRla-Mediated |M Inhibition
The agonist pharmacology of mGluRla-mediated IM inhibition was characterized as illustrated in Figure 6 . To generate concentration-response curves, increasing concentrations of agonist were sequentially applied to a mGluRl~-injected neuron, and the magnitude of I~ inhibition was determined when the response had reached a steady value. Because recovery from IM inhibition was relatively slow (see Figure 5B ) and often incomplete (especially after prolonged administration of agonist), agonist concentrations were applied before recovery from the previous concentration had occurred (i.e., the data represent a cumulative concentration-response curve). Normalized agonist concentration-response curves were generated In both (A) and (B), PTX-treated neurons were incubated overnight (12-15 hr) with culture media containing 500 ng/ml PTX. In inhibition was determined as in Figure 5 . The number of neurons tested are indicated in parentheses. Single asterisk, p ~< .05; double asterisks, p ~ .01 (unpaired Student's t test).
as in Figure 3 . For mGluRl(z-mediated IM inhibition, the rank order of agonist potency was L-quisqualate > L-glutamate > (1S,3R)-ACPD >> L-AP4, DCG-IV. The mean ECs0 for L-quisqualate (n = 5), L-glutamate (n = 5), and (lS,3R)-ACPD (n --5) inhibition of IM was 0.044 ± 0.005 I~M, 0.66 ± 0.06 I~M, and 10 _+ 4 I~M, respectively, and the maximum inhibition was 75% ± 4%, 77% _+ 3%, and 64% + 7%, respectively. Application of 10 I~M DCG-IV and 100 [~M L-AP4 resulted in 6.4% _ 2.4% (n = 4) and 3.0% ± 0.8% (n --2) inhibition of IM, respectively. The ability of (+)-MCPG (the active enantiomer) to block the inhibition of IM produced by application of L-glutamate was examined (data not shown). Application of agonist in the absence or presence of (+)-MCPG was performed on different neurons, as recovery from IM inhibition was often incomplete. In the absence or presence of 500 I~M (+)-MCPG, application of 10 I~M L-glutamate resulted in 79% + 8% (n --4) and 58% __. 7% (n = 5) inhibition of IM, respectively. However, the difference in mean inhibition was not significant (p = .1).
Signal Transduction Pathways
The role of G proteins in the signal transduction pathway through which activation of mGluR2 inhibits lea was investigated ( Figure 7A ). Guanosine 5'-O-2-thiodiphosphate (GDP-I~-S), a hydrolysis-resistant GDP analog, has been shown to attenuate G protein-mediated responses (Holz et al., 1986; Wanke et al., 1987) , perhaps by acting as a competitive inhibitor of GTP binding to G(z subunits (Eckstein et al., 1979) . Inhibition of Ica by L-glutamate (100 I~M) was determined 5 min after dialysis of a mGluR2-injected neuron with a pipette solution containing either 0.3 mM GTP ( Figure 7A , top open bar) or 2 mM GDP-13-S (without GTP; Figure 7A , hatched bar). Mean Ico inhibition in the absence or presence of internal GDP-I~-S was 53% __. 6.3% (n = 8) and 7.1% _.+ 3.4% (n = 6), respectively, thus implicating the participation of a G protein in the transduction pathway. Experiments to identify further the G protein subtype were carried out on pertussis toxin (PTX)-treated neurons. PTX is known to catalyze the ADPribosylation of a carboxy-terminal cysteine on the (z subunit of PTX-sensitive G proteins (G~ and Go), thereby disrupting pathways that utilize these elements (Hepler and Gilman, 1992) . PTX treatment abolished the mGluR2-mediated Ico inhibition; mean Ic~ inhibition produced by L-glutamate (100 I~M) was 69°/0 __. 30/o (n = 5) and -2.7°/o ± 0.9% (n = 6) for control ( Figure 7A , lower open bar) and PTXtreated neurons ( Figure 7A , closed bar), respectively.
Analogous experiments were performed to investigate signal transduction pathways involved in mGluRl(z-mediated IM inhibition ( Figure 7B ). Dialysis of mG luR1 (z-injected neurons with GDP-I~-S significantly (p < .05) reduced IM inhibition by L-glutamate (100 ~M) in mGluRl(z-injected neurons. Mean IM inhibition in the absence ( Figure 7B , upper open bar) or presence ( Figure 7B , hatched bar) of internal GDP-I~-S was 79% _ 11% (n = 4) and 26% __. 11% (n = 4), respectively. Conversely, PTX treatment had no effect on mGluRl(z-mediated IM in.hibition. Mean IM inhibition produced by L-glutamate (100 tIM) was 790/0 _ 6% (n = 6) and 76% ± 5% (n = 7), for control ( Figure  7B , lower open bar) and PTX-treated neurons ( Figure 7B , closed bar), respectively.
Discussion
In this study, we have demonstrated that injection of cRNA into the cytoplasm of adult mammalian sympathetic neurons results in rapid and robust expression of mGluRs that functionally couple to endogenous voltage-gated ion channels. As currently available pharmacological agents have a limited ability to discriminate among the growing number of mGluR subtypes, our current knowledge of the physiological roles subserved by specific mGluR subtypes relies heavily on extrapolation from nonneuronal preparations. The experimental strategy presented here thus fills an important void in our understanding of mGluR function by providing a means of investigating the interaction between unambiguously identified mGluR subtypes and neuronal ion channels.
Sympathetic Neurons as Expression Hosts
Mature sympathetic neurons, as a heterologous expression host, are endowed with several properties useful for studying G protein-coupled receptor function. First, sympathetic neurons possess a fairly homogenous complement of well studied voltage-gated ion channels to which expressed receptors might potentially couple. For example, modulation of N-type Ca 2+ channels and M-type K + channels--proteins that participate in the regulation of neurotransmitter release and neuronal excitability--has been studied extensively in this cell type (reviewed by Hille, 1994) . Second, we detected expression within 14-24 hr following injection. As a consequence, recordings were made before significant neurite formation, and thus degradation of voltage-clamp fidelity due to inadequate space-clamping occurred. In addition, the rapid expression observed in these studies compares favorably with the weeks, or even months, required for stable transfection studies. Third, expression was detected in nearly every injected cell, an advantage when compared with the variable expression rates achievable with other systems of transient transfection (e.g., calcium phosphate precipitation or lipofection). Fourth, in this study, mGluR subtypes were expressed against a "null" background. Thus, the mGluR subtype mediating a response was unambiguously defined, and interference from other mGluR and iGluR subtypes was eliminated. This obviated the need for complex pharmacological mixtures of antagonists--often a requirement when attempting to assess the contribution of a specific mGluR subtype in CNS neurons--that could potentially confound data interpretation. Finally, we anticipate that sympathetic neurons, as expression hosts, will be generally useful for the study of G protein-coupled receptor structure/function. There are few, if any, expression systems in which mutant~chimeric receptors can be rapidly expressed and tested for functional coupling to neuronal ion channels. To date, studies of chimeric mGluR receptor function have been determined from biochemical assays (e.g., changes in cAMP or IP3) in transfected nonneuronal cells (O'Hara et al., 1993; Takahashi et al., 1993; Pin et al., 1994) . Thus, our knowledge of the requirements for mGluR coupling to the G protein subtype Go, presumably important to N-type Ca 2+ channel modulation in SCG neurons (Caulfield et al., 1994) , is minimal.
Coupling of mGluRs to Ion Channels
Using this neuronal expression system, we have demonstrated that mGluR2 couples to N-type Ca 2+ channels via a PTX-sensitive pathway, mGluR2-mediated Ic~ inhibition was characterized by a slowing of current activation, pronounced voltage dependence of inhibition, and partial relief of block by depolarizing conditioning pulses. Such characteristics are produced by activation of several native G protein-coupled receptors and define the major pathway for Ica modulation in sympathetic neurons (reviewed by Hille, 1994) . That mGluR2 follows this profile of Ica inhibition is consistent with the fact that most, if not all, endogenous receptors in SCG neurons that utilize the PTX-sensitive voltage-dependent pathway are also known to negatively couple to AC. In addition, the expression of mGluRl~, a subtype that does not inhibit AC when expressed in nonneuronal cells, produced minimal Ca 2+ channel modulation. However, the relationship between AC inhibition and Ioa inhibition is probably not causal, as it is well established that N-type Ca 2+ channels of rat sympathetic neurons are relatively insensitive to modulation by cAMP (Wanke et al., 1987; Ikeda and Schofield, 1989) . Thus, it is likely that the signal transduction pathways mediating these responses diverge subsequent to agonistreceptor binding, a notion supported by the observations that G~ mediates AC inhibition (Hepler and Gilman, 1992) , and Go may mediate Ica modulation (Caulfield et al., 1994) . It remains to be determined whether other mGluR subtypes (mGluR3, mGluR4, mGluR6, and mGluR7) that negatively couple to AC also inhibit N-type Ca 2+ channels.
Our studies also demonstrate that mGluRla, but not mGluR2, couples to M-type K + channels via a PTXinsensitive pathway when expressed in SCG neurons. This result is consistent with the fact that both muscarine (Brown et al., 1989) and angiotensin II (Shapiro et al., 1994) , agents that produce IM inhibition in SCG neurons via a PTX-insensitive pathway, act through receptors known to increase IP3 formation. However, neither IP~ nor diacylglycerol appear to be directly involVed in the mechanism of IM inhibition (Brown et al., 1989) . Thus, it is possible that activation of Gq~, represents the event common to both IM inhibition (Caulfield et al., 1994) and phospholipase C activation. Interestingly, both muscarine Bernheim et al., 1991) and angiotensin II (Shapiro et al., 1994) have been shown to suppress Ica in SCG neurons through a novel pathway that is PTX insensitive, voltage independent, nonmembrane delimited, and sensitive to intracellular Ca 2+ buffers; thus, it will be important to determine in future experiments whether mGluRlcz produces Ica inhibition under similar conditions.
Comparison of Heterologous Expression in SCG .... Neurons and Nonneuronal Cells
The identification of mGluR subtypes mediating ion chan-: nel modulation in CNS neurons relies heavily on comparing the agonist pharmacology of CNS neurons with nonneuronal cells expressing mGluRs. The difficulties in performing binding studies on mGluRs (e.g., low affinity of ligands and nonspecific binding contributed by reuptake mechanisms) have resulted in the agonist pharmacology of the cloned mGluRs being derived almost exclusively from biochemical assays. Thus, it is important to compare the results of this study with those obtained from nonneuronal;:expression systems. For mGluR2-mediated Ic~ inhibition in SCG neurons, the rank order of agonist potency (DCG-IV > L-glutamate > (lS,3R)-ACPD) was identical to data obtained from measuring agonist-induced suppression of forskolin-stimulated cAMP production in CHO cells stably transfected with mGluR2 Hayashi et al., 1993) . In both systems, these agonists had similar efficacy (i.e., none were partial agonists) and ECho values (cf. 0.1 and 0.3 pM, DCG-IV; 1.8 and 4 p.M, L-glutamate; and 3.7 and 5 I~M, (lS,3R)-ACPD; for SCG and CHO cells, respectively). Moreover, MCPG was an effective.antagonist of, and PTX-pretreatment abolished, the mGluR2-mediated responses in both SCG neurons and CHO cells Hayashi et al. 1994) . Thus, there is reasonably good agreement between the two systems despite the disparity in expression host and response measured, Conversely, comparison of mGluR1 (~-mediated IM inhibition in SCG neurons with IP formation in nonneuronal (CHO, BHK, and HEK293) cells reveals several discrepancies. First, although the rank order of agonist potency for L-quisqualate, L-glutamate, and (1S,3R)-ACPD was the same for neuronal and nonneuronal cells, the agonist potency was considerably greater for IM inhibition. For example, the ECso for mGluRl(z-mediated IP turnover in BHK cells (Thornsen et al., 1993) was 3, 12, and 98 I~M for L-quisqualate, L-glutamate, and (lS,3R)-ACPD, respectively-values at least an order of magnitude greater than the those for IM inhibition (see Figure 6B ). Second, L-quisqualate and ACPD are partial agonists (when compared with L-glutamate) in CHO cells ) but full agonists (or at least had comparable efficacy) in SCG neurons. Third, MCPG is an effective antagonist of L-glutamate in mGluRl(z-expressing CHO cells (Hayashi et al., 1993) but had minimal effect in SCG neurons. The reason for this difference is unclear but may relate to the high potency of glutamate agonists in mGluRl(~-expressing SCG neurons (see above) and the fact that MCPG, although selective for mGluRs relative toiGluRs, is a relatively weak competitive antagonist . Fourth, mGluRl(x-mediated IP turnover in both CHO and BHK cells is partially (40O/o-500/0) inhibited by PTX pretreatment. In contrast, mGluRle.mediated inhibition of IM in SCG neurons was not significantly affected by PTX pretreatment (see Figure 7B) . Thus, data obtained from mGluRl(z-transfected nonneuronal cells are only moderately predictive of the characteristics of mGluRl(~-mediated ion channel modulation in neurons. Moreover, the discrepancy in results obtained among different nonneuronal expression hosts stably transfected with mGluRl(~ (e.g., Gabellini et al., 1994) underscores the need to develop alternative neuronal expression systems.
Functional Correlates in CNS Neurons
The mGluR2-mediated inhibition of Ica observed in SCG neurons appears to have correlates in the CNS. For example, DCG-IV or L-CCG-I, agonists selective for mGluR2/3 (Hayashi et al., 1992 (Hayashi et al., , 1993 , produce synaptic depression at corticostriatal synapses (Lovinger and McCool, 1995) and inhibition of high threshold Ic, in cerebellar granule cells (Chavis et al., 1994) and Cortical neurons (unpublished data). Moreover, DCG-IV inhibits 7-aminobutyric acid release from gran~Jle cells of the accessory olfactory bulb, presumably through the activation of mGluR2 (Hayashi et al., 1.993 Jahr, 1990; Swartz and Bean, 1992; Hay and Kunze, 1994) and L-AP4 (Trombley and Westbrook, 1992; Sahara and Westbrook, 1993 ), a result not seen in this study, has been reported. Thus, we assume that additional mGluR subtypes distinct from mGluR2 must also mediate Ica modulation in CNS neurons. In this regard, the results of Swartz and Bean (1992) are of particular interest. In this study, L-glutamate produced an inhibition of N-type Ca 2+ channels in dissociated rat hippocampal CA3 neurons accompanied by much of the same voltage-dependent phenomenology observed for mGluR2-mediated ica inhibition in SCG neurons (see Figure 2) . In contrast to the present result, however, L-quisqualate was the most potent agonist in hippocampal neurons. The finding that Ica in mGluRl(~-expressing SCG neurons (see Figure 1C ) was only slightly modulated by L-glutamate (see Figure 1C) suggests that another group I mGluR (i.e., splice variants of mGluR1 or mGluR5), or possibly a novel mGluR, is responsible for Ic, inhibition in CA3 hippocampal neurons. Alternatively, it is possible that mGluRl(z, the sole mGluR subtype shown to stimulate AC in nonneuronal cells O'Hara et aL, 1993) , mediates inhibition of N-type Ca 2÷ channels via a recently described pathway (Zhu and Ikeda, 1994) involving the activation of Gs. In this case, the weak mGluRl~-mediated inhibition of Ica in SCG neurons might be related to the level of receptor expression (see O'Hara et al., 1993) .
The observations that mGluR agonists produce IM inhibition in neurons of the hippocampus (Charpak et al., 1990) , nucleus of the solitary tract (Glaum and Miller, 1992) , and basolateral amygdala (Womble and Moises, 1994 ) provide a functional correlate to our findings with heterologously expressed mGluRlm The mGluR subtype mediating IM inhibition in CNS neurons is currently unresolved. However, the report that L-quisqualate inhibits IM in hippocampal neurons (Charpak et al., 1990 ) is consistent with our observations. The inability of mGluR2 to modulate IM (see Figure 5C ) reinforces the notion that mGluRs couple to specific ion channels.
Experimental Procedures Neuron Preparation and ¢RNA Injection
Single SCG neurons were enzymatically dissociated from 150.-400 g male or female Wistar rats as previously described (Ikeda, 1991; Zhu and Ikeda, 1994) . After allowing 2-4 hr for the neurons to attach firmly to the substrate (poly-D-lysine), neurons were microinjected using an Eppendorf 5242 pressure (N2) microinjector and 5171 micromanipulator system with cR NA (pipette concentration, 0.5-2.5 p.g/Id). The cRNA was mixed with a coinjection marker (10,000 MW fluorescein dextran, 0.1% in water) as previously described . Injection pressures and durations of 120-200 hPa and 0.4-0.5 s, respectively, resulted in an estimated 10% increase in cell volume, cRNA was in vitro transcribed in the presence of cap analog mT(5')ppp(5')G from linearized plasmids (pBluescript II KS+) using mMessage mMachine kits (Ambion) per the instructions of the manufacturer. After incubation (37°C, 5% CO2 in air) in culture media (minimal essential media supplemented with 10% fetal calf serum and 1% penicillin-streptomycin [GIBCO]) for 14.-24 hr, injected neurons were identified with an in-'k, erted microscope (Diaphot, Nikon, Japan) equipped with an epifluorescence unit. PTX (final concentration, 500 ng/ml; List Biologicals) was added to culture rfiedia 1-2 hr following neuron.injection.
Electrophysiology
Whole-cell currents were recorded with a patch-clamp amplifier (Axopatch 200A or 1 D, Axon Instruments) at room temperature (21-24°C) using the ruptured-membrane variant of the patch-clamp technique (Hamill et al., 1981) as previously described (Zhu and Ikeda, 1994) . For recording of Ic~, the external solution consisted of 140 mM tetraethylammonium hydroxide, 10 mM HEPES, 10 m M CaCI2, 15 mM glucose, and 0.0001 mM tetrodotoxin (pH adjusted to 7.4 with methanesulfonic acid). Patch electrodes (2-6 M~) were filled with a solution consisting of 125 mM N-methyI-D-glucamine, 20 mM tetraethylammonium-OH, t0 mM HEPES, 11 mM EGTA, 1 mM CaCI2, 14 mM Tris-creatine phosphate, 4 mM MgATP, 0.3 mM Na2-GTP (pH adjusted to 7.2 with methanesulfonic acid and HCI [final CI-concentration of 20 raM]). Ica traces were filtered at 2-5 KHz and digitized at 5 KHz. For In recordings, external solution consisted of 150 mM NaCI, 2.5 mM KCI, 10 mM HEPES, 1 mM MgCI2, 1 mM CaCI2, 15 mM glucose, 0.0001 mM tetrodotoxin (pH adjusted to 7.4 with NaOH). Patch electrodes (1-4 M~) were filled with a solution consisting of 150 mM KCI, K4-BAPTA (1,2-bis-(o-aminophenoxy)ethane-N,N,N',N'-tetracetic acid, 0.1), 10 mM HEPES, 4 mM Mg-ATP, 0.1 mM Na2-GTP (pH adjusted to 7.2 with KOH). IM traces were filtered at 0.5-1 KHz and digitized at 500 Hz. Drugs were applied from a large-bore macropipette positioned near (20-30 pro) the neuron of interest. L-quisqualate, (lS,3R)-ACPD, (1R,3S)-ACPD, (___) MCPG, (+) MCPG, L-SOP, and L-AP4 were purchased from Tocris Neuramin (United Kingdom). L-glutamate was purchased from Fisher Scientific (USA). Na2-GTP, Tris-creatine phosphate, and Li3-GDP-13-S were purchased from Sigma (USA). DCG-IV was kindly provided by Drs. H. Shinozaki and Y. Ohfune.
Analysis
Ca 2+ current traces and current-voltage relationships were corrected for linear leakage current as determined from hyperpolarizing pulses. Ica amplitude was determined isochronally 10 ms after the onset of a test pulse unless otherwise noted. M current traces were not leak subtracted. Nonlinear least squares regression of binding isotherm data was performed with curve-fitting routines (Marquardt-Levenberg algorithm) in Igor (WaveMetrics, USA). Data were expressed as means 4-_ SEM as appropriate. Student's t test (unpaired) was applied to determine statistical significance. The differences were considered significant if p ~< .05.
